Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Payton A-B Weidenbacher

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
NPJ Vaccines|January 9, 2024
Bringing immunofocusing into focusSriharshita Musunuri, Payton A B Weidenbacher, Peter S Kim
Biorxiv : the Preprint Server for Biology|June 19, 2024
Engineering a SARS-CoV-2 vaccine targeting the RBD cryptic-face via immunofocusingTheodora U J Bruun, Jonathan Do, Payton A-B Weidenbacher, et al.
ACS Central Science|October 28, 2024
Engineering a SARS-CoV-2 Vaccine Targeting the Receptor-Binding Domain Cryptic-Face via ImmunofocusingTheodora U J Bruun, Jonathan Do, Payton A-B Weidenbacher, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Decreased efficacy of a COVID-19 vaccine due to mutations present in early SARS-CoV-2 variants of concernPayton A-B Weidenbacher, Natalia Friedland, Mrinmoy Sanyal, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2023
Designing epitope-focused vaccines <i>via</i> antigen reorientationDuo Xu, Chunfeng Li, Ashley Utz, et al.
ACS Chemical Biology|April 12, 2022
Chemically Modified Bacterial Sacculi as a Vaccine Microparticle ScaffoldPayton A-B Weidenbacher, Frances P Rodriguez-Rivera, Mrinmoy Sanyal, et al.
Nature Chemical Biology|January 15, 2024
Vaccine design via antigen reorientationDuo Xu, Joshua J Carter, Chunfeng Li, et al.
Nature Chemical Biology|September 8, 2022
Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitorsPayton A-B Weidenbacher, Eric Waltari, Izumi de Los Rios Kobara, et al.
Nature Communications|January 3, 2026
Structure and immunogenicity of an engineered soluble prefusion-stabilized EBV gB antigenRyan S McCool, Cory M Acreman, Abigail E Powell, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2023
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primatesPayton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
NPJ Vaccines|January 9, 2024
Bringing immunofocusing into focusSriharshita Musunuri, Payton A B Weidenbacher, Peter S Kim
Biorxiv : the Preprint Server for Biology|June 19, 2024
Engineering a SARS-CoV-2 vaccine targeting the RBD cryptic-face via immunofocusingTheodora U J Bruun, Jonathan Do, Payton A-B Weidenbacher, et al.
ACS Central Science|October 28, 2024
Engineering a SARS-CoV-2 Vaccine Targeting the Receptor-Binding Domain Cryptic-Face via ImmunofocusingTheodora U J Bruun, Jonathan Do, Payton A-B Weidenbacher, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Decreased efficacy of a COVID-19 vaccine due to mutations present in early SARS-CoV-2 variants of concernPayton A-B Weidenbacher, Natalia Friedland, Mrinmoy Sanyal, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2023
Designing epitope-focused vaccines <i>via</i> antigen reorientationDuo Xu, Chunfeng Li, Ashley Utz, et al.
ACS Chemical Biology|April 12, 2022
Chemically Modified Bacterial Sacculi as a Vaccine Microparticle ScaffoldPayton A-B Weidenbacher, Frances P Rodriguez-Rivera, Mrinmoy Sanyal, et al.
Nature Chemical Biology|January 15, 2024
Vaccine design via antigen reorientationDuo Xu, Joshua J Carter, Chunfeng Li, et al.
Nature Chemical Biology|September 8, 2022
Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitorsPayton A-B Weidenbacher, Eric Waltari, Izumi de Los Rios Kobara, et al.
Nature Communications|January 3, 2026
Structure and immunogenicity of an engineered soluble prefusion-stabilized EBV gB antigenRyan S McCool, Cory M Acreman, Abigail E Powell, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2023
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primatesPayton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
Pageof 2